1350 Results for "

reversibility

" in MedChemExpress (MCE) Product Catalog:
Products (1350)

1350 Results for "reversibility" in MCE Product Catalog:

885
885 Publications Verification
Referencia número: HY-100558
No. CAS: 88899-55-2
Pureza:  99.95%
Synonyms: BafA1
Bafilomycin A1 (BafA1) is a specific and reversible inhibitor of vacuolar H +-ATPase (V-ATPase) with IC50 values of 4-400 nmol/mg. Bafilomycin A1, a macrolide antibiotic, is also used as an autophagy inhibitor at the late stage. Bafilomycin A1 blocks autophagosome-lysosome fusion and inhibits acidification and protein degradation in lysosomes of cultured cells. Bafilomycin A1 induces apoptosis .
loading...
    loading...
612
612 Cited Publications
Referencia número: HY-12041
No. CAS: 129-56-6
Pureza:  99.73%
Áreas de investigación:  

Cancer

SP600125 is an orally active, reversible, and ATP-competitive JNK inhibitor with IC50s of 40, 40 and 90 nM for JNK1, JNK2 and JNK3, respectively. SP600125 is a potent ferroptosis inhibitor. SP600125 induces the transformation of bladder cancer cells from autophagy to apoptosis .
loading...
    loading...
306
306 Cited Publications
Referencia número: HY-13030
No. CAS: 1268524-70-4
Pureza:  99.90%
Synonyms: JQ1
(+)-JQ-1 (JQ1), a chemical probe, is a potent, specific, CNS-penetrant and reversible BET bromodomain inhibitor, with IC50s of 77 and 33 nM for the first and second bromodomain (BRD4(1/2)) . (+)-JQ-1 also activates autophagy .
loading...
    loading...
271
271 Cited Publications
Referencia número: HY-10227
No. CAS: 179324-69-7
Pureza:  99.91%
Synonyms: PS-341; LDP-341; NSC 681239
Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Bortezomib can be used for the study of multiple myeloma (MM) . Bortezomib effectively inhibits TREM2 expression in tumor-associated macrophages (TAMs) .
loading...
    loading...
128
128 Cited Publications
Referencia número: HY-13520
No. CAS: 31430-18-9
Pureza:  99.59%
Synonyms: Oncodazole; R17934
Áreas de investigación:  

Cancer

Nocodazole (Oncodazole) is a rapidly-reversible inhibitor of microtubule. Nocodazole binds to β-tubulin and disrupts microtubule assembly/disassembly dynamics, which prevents mitosis and induces apoptosis in tumor cells. Nocodazole inhibits Bcr-Abl.
loading...
    loading...
110
110 Cited Publications
Referencia número: HY-12248
No. CAS: 1439399-58-2
Pureza:  99.82%
Synonyms: CB-839
Target:  

Glutaminase Autophagy

Áreas de investigación:  

Cancer

Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity .
loading...
    loading...
110
110 Cited Publications
Referencia número: HY-12248A
No. CAS: 1874231-60-3
Synonyms: CB-839 hydrochloride
Target:  

Glutaminase Autophagy

Áreas de investigación:  

Cancer

Telaglenastat (CB-839) hydrochloride is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat hydrochloride selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat hydrochloride inudces autophagy and has antitumor activity .
loading...
    loading...
104
104 Cited Publications
Referencia número: HY-15465
No. CAS: 139298-40-1
Pureza:  99.42%
Target:  

CaMK Autophagy

Áreas de investigación:  

Cancer

KN-93 is a cell-permeable, reversible and competitive inhibitor calmodulin-dependent kinase type II (CaMKII) with a Ki of 370 nM.
loading...
    loading...
104
104 Cited Publications
Referencia número: HY-15465A
No. CAS: 1956426-56-4
Pureza:  99.64%
Target:  

CaMK Autophagy

Áreas de investigación:  

Cancer

KN-93 hydrochloride is a cell-permeable, reversible and competitive inhibitor calmodulin-dependent kinase type II (CaMKII) with a Ki of 370 nM.
loading...
    loading...
104
104 Cited Publications
Referencia número: HY-15465B
No. CAS: 1913269-12-1
Pureza:  99.67%
Target:  

CaMK Autophagy

Áreas de investigación:  

Cancer

KN-93 phosphate is a cell-permeable, reversible and competitive inhibitor calmodulin-dependent kinase type II (CaMKII) with a Ki of 370 nM .
loading...
    loading...
94
94 Cited Publications
Referencia número: HY-14879A
No. CAS: 1192491-61-4
Pureza:  99.99%
Synonyms: NXL-104
Áreas de investigación:  

Infection

Avibactam sodium (NXL-104) is a covalent and reversible non-β-lactam β-lactamase inhibitor which inhibits β-lactamase TEM-1 and CTX-M-15 with IC50s of 8 nM and 5 nM, respectively .
loading...
    loading...
94
94 Cited Publications
Referencia número: HY-14879B
No. CAS: 2938989-90-1
Pureza:  98.66%
Synonyms: NXL-104 hydrate
Áreas de investigación:  

Infection

Avibactam sodium (NXL-104) hydrate is a covalent and reversible non-β-lactam β-lactamase inhibitor which inhibits β-lactamase TEM-1 and CTX-M-15 with IC50s of 8 nM and 5 nM, respectively .
loading...
    loading...
94
94 Cited Publications
Referencia número: HY-14879
No. CAS: 1192500-31-4
Pureza:  99.22%
Synonyms: NXL-104 free acid
Áreas de investigación:  

Infection

Avibactam (NXL-104) free acid is a covalent and reversible non-β-lactam β-lactamase inhibitor which inhibits β-lactamase TEM-1 and CTX-M-15 with IC50s of 8 nM and 5 nM, respectively .
loading...
    loading...
84
84 Cited Publications
Referencia número: HY-100526
No. CAS: 2061980-01-4
Pureza:  99.24%
Target:  

Hippo (MST)

Áreas de investigación:  

Cancer

XMU-MP-1 is a reversible and selective MST1/2 inhibitor with IC50s of 71.1 and 38.1 nM, respectively .
loading...
    loading...
64
64 Cited Publications
Referencia número: HY-13805
No. CAS: 172889-27-9
Pureza:  98.34%
Synonyms: AGL 1879
Target:  

Src

Áreas de investigación:  

Cancer

PP2 is a reversible and ATP-competitive Src family kinases inhibitor with IC50s of 4 and 5 nM for Lck and Fyn, respectively.
loading...
    loading...
56
56 Cited Publications
Referencia número: HY-15723
No. CAS: 733767-34-5
Pureza:  99.86%
Target:  

Ras

Áreas de investigación:  

Cancer

NSC 23766 is a cell-permeable, reversible and specific inhibitor of Rac GTPase, used for cancer treatment.
loading...
    loading...
54
54 Cited Publications
Referencia número: HY-100514
No. CAS: 1652591-81-5
Pureza:  99.48%
GSK484 hydrochloride is a selective and reversible peptidylarginine deiminase 4 (PAD4) inhibitor. GSK484 hydrochloride demonstrates high affinity binding to PAD4 with IC50s of 50 nM in the absence of Calcium. In the presence of 2 mM Calcium, notably lower potency (250 nM) is observed.
loading...
    loading...
52
52 Cited Publications
Referencia número: HY-15816A
No. CAS: 1956366-10-1
Pureza:  99.89%
Synonyms: BVD-523 hydrochloride; VRT752271 hydrochloride
Target:  

ERK

Áreas de investigación:  

Cancer

Ulixertinib hydrochloride (BVD-523 hydrochloride) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib hydrochloride inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line .
loading...
    loading...
52
52 Cited Publications
Referencia número: HY-15816
No. CAS: 869886-67-9
Pureza:  99.95%
Synonyms: BVD-523; VRT752271
Target:  

ERK

Áreas de investigación:  

Cancer

Ulixertinib (BVD-523; VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib (BVD-523; VRT752271) inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line .
loading...
    loading...
44
44 Cited Publications
Referencia número: HY-13867
No. CAS: 133052-90-1
Pureza:  98.15%
Synonyms: GF109203X; Go 6850
Target:  

PKC GSK-3

Áreas de investigación:  

Metabolic Disease Cancer

Bisindolylmaleimide I (GF109203X) is a cell-permeable and reversible PKC inhibitor (IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ. Bisindolylmaleimide I is also a GSK-3 inhibitor .
loading...
    loading...